Point-of-care platform to detect and measure a panel of protein biomarkers released into the bloodstream after a Traumatic Brain Injury.
Unique and proprietary technology that offers:
Not FDA approved and currently for research use only. Not for use in diagnostic procedures.
BioDirection is always searching for new opportunities. Contact us today with any questions or inquiries.